Ad
related to: moderna vaccine
Search results
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 3 days agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 7 days agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 3 days agoFortunately, there are good reasons to believe the company has what it takes. Moderna is inching...
What's Going With Moderna Stock On Friday? - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoThe agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory ...
Quick takes: Moderna's RSV vaccine, flu-COVID combo vaccines, new polio cases
Center for Infectious Disease Research and Policy· 4 days agoThe FDA has pushed back its review of Moderna's RSV vaccine owing to administrative issues.
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 7 days agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 6 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...